Dr Prem Kumar Nair
Group Chief Executive Officer
Date of Appointment1 October 2023
Dr Prem Kumar Nair
NationalitySingaporean
GenderMale
Age65 (As at 31 March 2026)
Dr Prem Kumar Nair was appointed Group Chief Executive Officer of IHH Healthcare on 1 October 2023, where he leads a team of 76,000 employees to realise IHH’s vision to be the world’s most trusted healthcare services network.
Dr Nair sets the strategic direction for the sustainable growth of IHH’s global network, which today comprises 190 healthcare facilities, including 89 hospitals in 10 countries. Guided by its Care. For Good. aspiration, Dr Nair continues to build on the IHH portfolio of strong and reputable brands including Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court - to touch lives and transform care globally.
Before his role as Group CEO, he served as CEO of IHH Singapore since 2020, where he oversaw the country’s business units and played a pivotal role in strategic growth and international outreach. Prior to that, Dr Nair was with Raffles Medical Group for 27 years, where he held concurrent roles as Chief Corporate Officer, and Managing Director for Singapore Healthcare.
With four decades of experience as a physician and healthcare executive in both public and private sectors, Dr Nair has earned accolades such as Executive of the Year (Healthcare) at the SBR Management Excellence Awards 2025, Asia’s Best CEO at the Corporate Governance Asia - Asian Excellence Award 2024 and 2025, and Wellbeing CEO at the WorkWell Leaders Award 2024.
An active community citizen in Singapore, Dr Nair was a recipient of the Public Service Medal (Pingat Bakti Masyarakat) in 2010 and, at the 2022 National Day Awards, he received both the Public Service Star (Bintang Bakti Masyarakat) and the Public Service Medal (PBM COVID-19), respectively, for his contributions to the Singapore Prison Service and his support of national COVID-19 efforts. He is a Justice of the Peace and an Adjunct Associate Professor at the National University of Singapore’s Saw Swee Hock School of Public Health. Dr Nair also serves as a Member of the Board of Governors for Sidra Medicine (Qatar) and a Member of the Board of Visiting Justices, Singapore Prison Service.
